Pay in 4 interest-free payments of $27.45 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
InChiKey: MMMNTDFSPSQXJP-UHFFFAOYSA-N
on platelet and renal prostaglandin-endoperoxide metabolism
1007/s00109-014-1155-0
BRL 43694A
[Epub ahead of print] PubMed PMID: 20525876
R428 - CAS# 1037624-75-1 R-623 InChiKey: MMMNTDFSPSQXJP-UHFFFAOYSA-NBemcentinib, also known as BGB 324 or R428, is a selective small molecule inhibitor of Axl kinase, which showed activity to blocks tumor spread and prolongs survival in models of metastatic breast cancer. The receptor tyrosine kinase Axl may play an important role in cancer progression, invasion, metastasis, drug resistance, and patient mortality. R428 inhibits Axl with low nanomolar activity and blocked Axl dependent events, including Akt
US$ 15.95
US$ 64.47
US$ 26.00
US$ 15.95